This site is intended for healthcare professionals only
LoginRegister
CDSCO Panel Seeks Revised Phase IV Study for Zydus Empagliflozin, Metformin FDCZydus Healthcare gets CDSCO Panel Nod To study FDC Empagliflozin plus Metoprolol Succinate
Synokem gets CDSCO Panel Nod To Study FDC Dapagliflozin plus Sacubitril plus ValsartanSynokem gets CDSCO Panel Nod To Study FDC Dapagliflozin plus Sacubitril plus Valsartan
Eli Lilly Announces USD 3.5 Billion US Manufacturing Facility for Next-Gen Obesity DrugsUSFDA delays decision on Eli Lilly Alzheimer's drug Donanemab
Lupin names Rakesh Bhardwaj as Chief Information OfficerLupin names Rakesh Bhardwaj as Chief Information Officer
Pill form of Wegovy gets USFDA approval for weight lossWorking with several countries authorities to tackle counterfeit versions of Ozempic: Novo Nordisk...
AstraZeneca Saphnelo subcutaneous self-administration recommended for approval in EU by CHMP for systemic lupus erythematosusAstraZeneca gets CDSCO Panel Nod To Import, Market Sodium Zirconium Cyclosilicate Powder for Oral...
Unrestricted Antibiotic Sales via E-Pharmacies: AIOCD Flags AMR Risk, Seeks PM Modis InterventionFrame policy for online sale of medicines: Delhi HC gives four-month deadline for Health Ministry
Surat Businessman Arrested in Rs 8.5 Crore Pharma Fraud, Probe on AccomplicesPharma Company CMD held for defrauding investor of Rs 70 crore
Pill form of Wegovy gets USFDA approval for weight lossNovo Nordisk Wegovy gets USFDA nod for lowering heart risks
CDSCO Panel Clears Bristol Myers Yervoy for Two New Cancer IndicationsUSFDA approves Opdivo in combo with Cisplatin and Gemcitabine for first-line treatment of adult...
USFDA Closes Inspection at Zydus Ankleshwar Unit-2 With Three ObservationsAlembic Pharma gets 4 USFDA observations for Panelav facility
Sun Pharma Recalls Dandruff, Acne Drugs, Cipla Pulls Lanreotide In USSun Pharma unit recalls over 54000 bottles of Mesalamine ER capsules in US
X